NCT01056770View on ClinicalTrials.gov

Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers

PHASE3CompletedINTERVENTIONAL

Enrollment

88

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions

Smallpox

Interventions

DRUG

smallpox vaccine CJ-50300

Conventional CJ-50300 2.5 x 100000 pfu/dose vaccination

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

HK inno.N Corporation

All Listed Sponsors

collaborator

HK inno.N Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER